Infectious disease consultation for candidaemia – Authors' reply

Carlos Mejia-Chew; Jane A. O'Halloran; Margaret A. Olsen; Dustin Stwalley; Amber Salter; William G. Powderly; Andrej Spec

doi:10.1016/S1473-3099(20)30005-0

Infectious disease consultation for candidaemia – Authors' reply

Carlos Mejia-Chew, Jane A. O'Halloran, Margaret A. Olsen, Dustin Stwalley, Amber Salter, William G. Powderly, Andrej Spec

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	165-166
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	20
Issue number	2
DOIs	https://doi.org/10.1016/S1473-3099(20)30005-0
State	Published - Feb 2020

Access to Document

10.1016/S1473-3099(20)30005-0

Cite this

@article{88fcd7ba2f2443c9b511ed98d0e1a11e,

title = "Infectious disease consultation for candidaemia – Authors' reply",

author = "Carlos Mejia-Chew and O'Halloran, {Jane A.} and Olsen, {Margaret A.} and Dustin Stwalley and Amber Salter and Powderly, {William G.} and Andrej Spec",

note = "Funding Information: MAO reports grants from the National Institutes of Health/National Center for Advancing Translational Sciences, the Agency for Healthcare Research and Quality, Sanofi Pasteur, Merck, and Pfizer, and personal fees from Pfizer. DS reports personal stock ownership in Bristol-Myers Squibb and AbbVie. WGP reports personal fees from Gilead Sciences and grants and personal fees from Merck. ASp reports grants from Astellas Pharma Global Development. CM-C, JAO'H, and ASa declare no competing interests.",

year = "2020",

month = feb,

doi = "10.1016/S1473-3099(20)30005-0",

language = "English",

volume = "20",

pages = "165--166",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

number = "2",

}

TY - JOUR

T1 - Infectious disease consultation for candidaemia – Authors' reply

AU - Mejia-Chew, Carlos

AU - O'Halloran, Jane A.

AU - Olsen, Margaret A.

AU - Stwalley, Dustin

AU - Salter, Amber

AU - Powderly, William G.

AU - Spec, Andrej

N1 - Funding Information: MAO reports grants from the National Institutes of Health/National Center for Advancing Translational Sciences, the Agency for Healthcare Research and Quality, Sanofi Pasteur, Merck, and Pfizer, and personal fees from Pfizer. DS reports personal stock ownership in Bristol-Myers Squibb and AbbVie. WGP reports personal fees from Gilead Sciences and grants and personal fees from Merck. ASp reports grants from Astellas Pharma Global Development. CM-C, JAO'H, and ASa declare no competing interests.

PY - 2020/2

Y1 - 2020/2

UR - http://www.scopus.com/inward/record.url?scp=85078266350&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(20)30005-0

DO - 10.1016/S1473-3099(20)30005-0

M3 - Letter

C2 - 32006500

AN - SCOPUS:85078266350

SN - 1473-3099

VL - 20

SP - 165

EP - 166

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 2

ER -

Infectious disease consultation for candidaemia – Authors' reply

Access to Document

Other files and links

Cite this